Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ)
CNY 23.75
(-0.88%)
CNY 23.75
(-0.88%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 580.52 Million CNY | 6.78% |
| 2022 | 543.67 Million CNY | 4.33% |
| 2021 | 521.11 Million CNY | 6.48% |
| 2020 | 489.39 Million CNY | 2177.24% |
| 2019 | 21.49 Million CNY | 705.14% |
| 2018 | 2.66 Million CNY | -97.67% |
| 2017 | 114.34 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 100.0% |
| 2013 | -16.15 Million CNY | 12.92% |
| 2012 | -18.55 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 564.03 Million CNY | -0.41% |
| 2024 Q1 | 559.6 Million CNY | 1.22% |
| 2024 Q2 | 566.33 Million CNY | 1.2% |
| 2023 Q3 | 576.13 Million CNY | -0.67% |
| 2023 Q1 | 550.29 Million CNY | 1.22% |
| 2023 Q2 | 580.01 Million CNY | 5.4% |
| 2023 FY | 580.52 Million CNY | 6.78% |
| 2023 Q4 | 580.52 Million CNY | 0.76% |
| 2022 Q3 | 531.71 Million CNY | 0.96% |
| 2022 FY | 543.67 Million CNY | 4.33% |
| 2022 Q2 | 526.63 Million CNY | 0.17% |
| 2022 Q1 | 525.75 Million CNY | 0.89% |
| 2022 Q4 | 543.67 Million CNY | 2.25% |
| 2021 Q1 | 504.92 Million CNY | 3.17% |
| 2021 FY | 521.11 Million CNY | 6.48% |
| 2021 Q3 | 513.35 Million CNY | 1.18% |
| 2021 Q2 | 507.38 Million CNY | 0.49% |
| 2021 Q4 | 521.11 Million CNY | 1.51% |
| 2020 Q1 | 19.07 Million CNY | -11.24% |
| 2020 Q3 | 483.68 Million CNY | 2615.52% |
| 2020 Q4 | 489.39 Million CNY | 1.18% |
| 2020 FY | 489.39 Million CNY | 2177.24% |
| 2020 Q2 | 17.81 Million CNY | -6.62% |
| 2019 Q1 | 2.44 Million CNY | -8.38% |
| 2019 FY | 21.49 Million CNY | 705.14% |
| 2019 Q4 | 21.49 Million CNY | -28.36% |
| 2019 Q2 | 2.21 Million CNY | -9.29% |
| 2019 Q3 | 30 Million CNY | 1252.43% |
| 2018 Q4 | 2.66 Million CNY | -96.14% |
| 2018 Q2 | 66.4 Million CNY | 7.79% |
| 2018 Q1 | 61.6 Million CNY | -46.12% |
| 2018 FY | 2.66 Million CNY | -97.67% |
| 2018 Q3 | 69.15 Million CNY | 4.14% |
| 2017 Q1 | 120.76 Million CNY | 0.0% |
| 2017 FY | 114.34 Million CNY | 0.0% |
| 2017 Q4 | 114.34 Million CNY | -5.23% |
| 2017 Q3 | 120.65 Million CNY | 2.19% |
| 2017 Q2 | 118.07 Million CNY | -2.23% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 100.0% |
| 2013 FY | -16.15 Million CNY | 12.92% |
| 2012 FY | -18.55 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 2.33 Billion CNY | 75.086% |
| Hangzhou Tigermed Consulting Co., Ltd. | 434.22 Million CNY | -33.694% |
| Dirui Industrial Co.,Ltd. | 3.66 Million CNY | -15731.157% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | 48.701% |
| Medicalsystem Biotechnology Co., Ltd. | 23.59 Million CNY | -2360.291% |
| Maccura Biotechnology Co.Ltd | 175.47 Million CNY | -230.828% |
| Guangdong Hybribio Biotech Co.,Ltd. | 28.26 Million CNY | -1953.629% |
| BGI Genomics Co., Ltd. | 283.42 Million CNY | -104.825% |
| Amoy Diagnostics Co., Ltd. | 44.4 Million CNY | -1207.499% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 166.83 Million CNY | -247.962% |